Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In this study we aimed to assess vitamin D levels in Hashimoto's Thyroditis (HT) patients, and demonstrate the relationship between these levels and thyroid function tests or thyroid autoantibodies.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

All participants were females between ages 18-65 years.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Correlation between Vitamin D levels and thyroid autoantibodies in newly diagnosed hashimoto's thyroiditis patients

Study design awaiting verification · African Health Sciences · 2025

Original publication title

Correlation between Vitamin D levels and thyroid autoantibodies in newly diagnosed hashimoto's thyroiditis patients

Ahmed Cihad Genç; Aysel Toçoğlu; Fatma Betül Asan; Attila Önmez

© 2025 Genç AC et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In conclusion, this study showed a higher prevalence of vitamin D deficiency in HT patients compared to healthy controls, and also a higher prevalence of HT in patients with either deficiency or insufficiency of vitamin D compared to individuals with normal vitamin D levels. While a negative correlation was found between vitamin D and anti-TPO levels, there was no significant relationship between vitamin D and TSH, fT4, fT3, and anti-TG values. More comprehensive and prospective studies are needed to clarify the relationship between thyroid autoimmunity and vitamin D, and to determine the role of vitamin D supplementation in the prevention and alleviation of thyroid autoimmunity.

In the meantime, vitamin D screening should be carried out at the time of diagnosis or during follow up of patients diagnosed with HT, and replacement should be recommended if necessary.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D plays a role in numerous metabolic functions. In this study we aimed to assess vitamin D levels in Hashimoto's Thyroditis (HT) patients, and demonstrate the relationship between these levels and thyroid function tests or thyroid autoantibodies.

Source: Background

Study methods

What methods does the paper describe?

This study included 112 patients who presented to the internal medicine clinics of our hospital between 01.03.2023 and 01.06.2023, and who were diagnosed with HT by laboratory tests. The study also included 178 healthy controls who presented for a health screening during the same time period. All participants were females between ages 18-65 years. Patients who smoked or consumed alcohol, had comorbidities, a history of thyroidectomy or pregnancy, hormone replacement prior to presentation, use of anti thyroid or drugs that could affect thyroid function (e.g. amiodarone, lithium), and a history of vitamin D or calcium replacement during the previous 6 months were not included.

The study was carried out according to the declaration of Helsinki. All procedures in the study were approved by the Duzce University Ethical Board (Ethical board number: 2023/149). Informed consents were not taken because the study was retrospective.

Demographic and Laboratory Data

Subject data including age, sex, laboratory studies, and thyroid ultrasound results were retrieved from clinic files and retrospectively recorded on the hospital information system. Height and weight measurements on the hospital records were used to calculate the body mass index (BMI) (kg/m2). Blood samples were taken after minimum 8 hours of fasting. Fasting blood glucose (FBG), urea, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) were assessed with Beckman Coulter AU5800 device, free tetraiodothyronine (fT4), free triiodothyronine (fT3), thyroid stimulating hormone (TSH), thyroid peroxidase antibody (anti-TPO), thyroglobulin antibody (Anti-TG), and 25-Hydroxyvitamin D (25-OH D) were assessed with Siemens Advia Centaur XPT device.

Diagnostic Criteria

HT was diagnosed with a positive thyroid antibody test (anti-TPO>60 IU/mL and/or anti-TG>4.5 IU/mL) and presence of diffuse heterogeneity on ultrasound consistent with chronic thyroiditis. Euthyroidism was defined with TSH (0.35-5.5 mIU/L) and fT4 (0.83 to 1.43 ng/dL) levels within the normal reference range. Based on previous studies and guidelines, a 25-OH D level <20 µg/L was classified as vitamin D deficiency, 20-29.9 µg/L as vitamin D insufficiency, and ≥30 µg/L as sufficient vitamin D14,15.

Statistical Analysis

Descriptive analyses were carried out to provide comprehensive insights into the fundamental characteristics of the study cohort. Both visual representations, encompassing probability plots and histograms, along with rigorous analytical techniques such as the Kolmogorov-Smirnov and Shapiro-Wilk's tests, were employed to detect the normal distribution status of the data. Parametric assessments, especially the Independent Sample t-test, were applied to compare these parameters. The examination of categorical variables between the two distinct groups was made by the chi-square test. The categorical variables were shown in terms of frequency percentages.

For the investigation of data with parametric attributes involving multiple samples and repeated measures, a Repeated Measures Variance Analysis (ANOVA) was made. In this context, the Greenhouse-Geisser correction method was used. Given the normal distribution of both variables, the Pearson correlation coefficient in conjunction with its associated significance levels was calculated. The correlation analysis was also separately conducted for distinct work status categories. p<0.05 was set for statistical significance. All analytical procedures were executed utilizing the SPSS statistical software (IBM SPSS Statistics, Version 22.0.

Armonk, NY: IBM Corp.).

Source: Methods Source: Methods Source: Methods Source: Methods

Abstract: Conclusıons

This study showed that EHT patients had lower vitamin D levels compared to healthy controls, and there was a significant negative correlation between vitamin D levels and anti-TPO levels. Based on our study, patients diagnosed with HT should undergo vitamin D screening, and replacement if necessary.

Source: Conclusıons

Introductıon

Hashimoto's thyroditis is a chronic autoimmune disease characterized by destruction of thyroid tissue, caused by lymphocytic infiltration. It has an annual incidence of 0.3-1.5 per 1000, and is the most common cause of hypothyroidism in areas of iodine sufficiency1,2. It is especially common in young and middle aged females, with a female to male ratio of 7/1 2. Although studies have stated that the disease is triggered by environmental factors in the presence of a genetic tendency, the etiology remains uncertain3.

The most commonly known risk factors include iodine excess, viral infections, chemicals, and drugs that stimulate antibody development such as amiodarone2. Recent studies focused on the efects of dietary factors, including deficiencies of vitamin D and selenium4. Because patients in early disease stages are generally euthyroid, they are asymptomatic and the diagnosis is made incidentally during routine screening. During the course, sublinical hypothyroidism, overt hypothroidism with or without goiter, or even thyroid cancer may develop sequentially5.

It is therefore important to detect and monitor the disease in the healthy population, and manage hypothyroidism.

Vitamin D is a secosteroid structured molecule produced in the skin. In addition to its fundamental role in bone mineralization and calcium metabolism, it also has important modulating effects on the immune system, exerted through the vitamin D receptor (VDR)6. Immunomodulator effects are exerted through VDR. Activation of VDR in immune cells leads to the transcription of gene products that trigger the antiproliferative and immune regulatory cascade6. Numerous studies have suggested that vitamin D deficiency is associated with autoimmune diseases, metabolic syndrome, chronic inflammatory disorders, cardiovascular diseases, and cancer7-10.

Despite numerous recent studies on the role of vitamin D in autoimmune thyroid diseases, the results are controversial11,12. There are also studies which suggest that vitamin D supplementation has a protective role in autoimmune thyroid diseases and thyroid cancers13.

The aim of this study is to analyze vitamin D levels in euthyroid Hashimoto's thyroiditis (EHT) patients and to demonstrate the relationship between vitamin D levels, thyroid function tests, and autoantibodies.

Source: Introductıon Source: Introductıon Source: Introductıon

Dıscussıon

Hashimoto's thyroiditis is the most common autoimmune thyroid disorder, and its incidence has shown an increase in recent years. During the course of the disease, patients may develop hypothyroidism, lymphoma possibly related to HT, and papillary thyroid cancer. An effective treatment that can prevent these has not been found 5. Based on the data acquired in the last 30 years, it is widely accepted that vitamin D plays a critical role in the modulation of the immune system. Although the pathogenesis of autoimmune thyroid diseases is not known completely, studies have shown a possible association between vitamin D deficiency and initiation or progression of the diseases16.

In our study we aimed to show the relationship between HT and vitamin D, and determine the correlation between thyroid function tests and autoantibodies with vitamin D levels.

The study included 290 women, 112 (38.6%) were EHT patients, and 178 (61.4%) were healthy controls. Mean age in the EHT group was 35±11 years, and was consistent with previous reports. Mean vitamin D level was 11.43±5.19 µg/L in the EHT group, and 14.53±8.25 in the healthy control group. Vitamin D level in the ETH group was significantly lower compared to the healthy control group (p<0.05). Also, when the subjects in both groups were classified according to vitamin D levels, the number of vitamin D deficient patients was significantly higher in the EHT group (90.2%) compared to the healthy group (74.7%) (p=0.001).

Similar to ours, previous studies found that HT patients had significantly lower levels of vitamin D and a higher prevalence of vitamin Deficiency compared to healthy controls17,18. Another study emphasized that there was a relationship between the severity of vitamin D and duration of HT, thyroid volume, and antibody levels. Also, vitamin D level had a potential role in the onset or progression of HT16. Contradictory to these data, a contemporary study published in 2021 and included 456 HT patients reported that there was no difference between HT patients and healthy controls with respect to vitamin D levels and prevalence of vitamin D deficiency4.

While the prevalence of vitamin D deficiency is investigated in HT patients, the prevalence of HT in patients with vitamin D deficiency was also studied. Studies showed that the incidence of HT is increased in patients with vitamin D deficiency, compared to those with normal vitamin D levels19,20. Prospective studies in which vitamin D replacement was given showed that anti-TPO and/or anti TG levels decreased significantly after vitamin D replacement. Ucan et al found that in EHT patients, vitamin D replacement led to a statistically significant decrease in antibody levels and thyroid volüme21.

In another study by Krysiak et al, the subjects received 2000 IU/day vitamin D replacement for 6 months22. At the end of this period serum vitamin D levels increased significantly, both anti-TPO and anti-TG levels decreased significantly with greater decreases in anti-TPO levels22. In our study, 80.7% of the patients had vitamin D deficiency and 14.8% had vitamin D insufficiency. Similar to previous tudies, comparison of the number of antibody positive patients and antibody titers between the groups showed that the anti-TPO and anti-TG levels and the number of anti-TPO positive patients were significantly higher in the groups with deficiency or insufficiency of vitamin D, compared to the group with sufficient vitamin D (p<0.001, p=0.026, p=0.006, respectively).

This showed us that there was a negative relationship between vitamin D levels and antibody levels.

Correlation analysis for determining the relationship between vitamin D and thyroid autoantibodies revealed statistically significant negative correlation between vitamin D levels and anti-TPO levels. (r=-0.133, p=0.023). Shin et al compared 111 antibody positive patients with 193 antibody negative patients, and found that levels of vitamin D were significantly lower in antibody positive patients23. In consistence with our study they also found a negative correlation between vitamin D and anti-TPO levels (r=-0.252; p<0.001)23. In some other important studies a negative correlation between vitamin D and anti-TG levels, however we did not find such a relationship20,24.

Studies evaluating the relationship between vitamin D and thyroid function tests showed that vitamin D level is associated with TSH, the higher the level of vitamin D the lower was the TSH level12,25. Chao et al found that with every 1ng/mL increase in vitamin D there was a 0.17 mIU/L decrease in TSH level, and they stated that vitamin D supplementation could play a role in preventing hypothyroidism15. However, this relationship was not confirmed by other studies.

A meta analysis that was published in 2021 and evaluated 6 clinical studies showed that vitamin D levels increased and anti-TPO titers decreased significantly with vitamin D replacement, however a relationship between vitamin D levels with thyroid function tests and anti-TG levels could not be found 26. Similarly, we did not find a significant correlation between vitamin D levels with either anti-TG levels or thyroid function tests. These findings show that anti-TPO is a better reflector of the effects of vitamin D on thyroid autoimmunity than the anti-TG.

The risk analysis in our study showed that in vitamin D deficiency, the presence of HT increased by 3.107 fold (OR: 3.107, %95 CI: 1.530-6.307, p= 0.001), and anti-TPO positivity increased by 2.604 fold (OR: 2.604, %95 CI: 1.280-5.291, p= 0.004). Mansournia et al showed that a 5 ng/ml increase in vitamin D level led to 19% decrease in odds of HT27.

Our study had some limitations. The retrospective and single center nature of the study, the relatively small number of EHT patients, and inclusion of only females were the major limitations. Although the lack of subclinical and overt hypothyroidism groups led to limitations in detecting the relationship between vitamin D and thyroid function tests, the inclusion of only newly diagnosed euthyroid patients rendered the patient group more specific. Another advantage of the study was its conduction in a single season to exclude seasonal factors.

Source: Dıscussıon Source: Dıscussıon Source: Dıscussıon Source: Dıscussıon Source: Dıscussıon Source: Dıscussıon

Results

A total of 290 women, including 112 (38.6%) EHT patients and 178 (61.4%) healthy controls, were included into the study. The demographic, anthropometric, and laboratory parameters of the EHT and healthy control groups are summarized in Table I. Mean age was 35.33±11.54 in the EHT group, and 35.84±10.95 in the healthy control group (p=0.777). Evaluation of the biochemical parameters showed that the EHT group had significantly higher levels of TSH, anti-TPO, and anti-TG levels (p<0.001), and lower fT4 and vitamin D levels compared to the healthy group (p<0.05).

Mean vitamin D level was 11.43±5.19 µg/L in the EHT group, and 14.53±8.25 µg/L in the healthy group. Classification of subjects in both groups with respect to vitamin D levels showed that the ratio of patients with vitamin D deficiency was significantly higher in the EHT than the healthy group (90.2% vs. 74.7%, respectively) (p=0.001). While there were 13 patients with normal vitamin D levels in the healthy group, there were no patients in the EHT group who had sufficient vitamin D levels.

Table I

Demographic, anthropometric, and laboratory parameters of EHT and healthy groups

Total (n=290)Healthy Group (n=178)EHT Group (n=112)p
Age, years 35.03±10.1735.84±10.9535.33±11.540.777
Sex, female, n(%) 290 (100)178 (100)112 (100)-
BMI, kg/m2 26.30±6.1825.65±5.2727.35±7.340.244
Glucose, mg/dL 90.56±8.0890.35±8.0590.89±8.160.945
Urea, mg/dL 23.15±6.8723.44±7.3622.69±6.010.572
Creatinine, mg/dL 0.61±0.100.62±0.100.60±0.110.159
AST, U/L 17.74±5.4917.83±5.1717.60±5.990.366
ALT, U/L 15.77±9.7215.43±8.3016.29±1.640.965
fT4, ng/dL 1.07±0.151.09±0.161.05±0.13 0.022
fT3, ng/L 3.09±0.153.07±0.523.13±0.490.387
TSH, mlU/L 1.99±1.021.78±0.882.33±1.14 <0.001
Anti TPO, IU/mL 234.23±432.6115.22±15.72582.30±536.38 <0.001
Anti TG, IU/mL 36.35±128.571.82±1.3493.23±195.16 <0.001
25-OH D, µg/L 13.33±7.3714.53±8.2511.43±5.19 0.007
Patient prevalence, n(%)
25-OH D<20 µg/L* 234 (80.7)133 (74.7)101 (90.2)
25-OH D:20-29.9 µg/L 43 (14.8)32 (18.0)11 (9.8) 0.001
25-OH D>30 µg/L* 13 (4.5)13 (7.3)0 (0.0)

*: There is a statistically significant difference between the groups. Abbreviations: EHT= Euthyroid Hashimoto's Thyroiditis, BMI= body mass index; AST= Aspartate aminotransferase; ALT= Alanine aminotransferase; fT4= free tetraiodothyronine; fT3= free triiodothyronine; TSH= thyroid stimulating hormone; Anti-TPO= thyroid peroxidase antibody; Anti-TG= thyroglobulin antibody; 25-OH D= 25-Hydroxy Vitamin D

The subjects were separated into 3 groups with respect to vitamin D levels: 234 (80.7%) had vitamin D deficiency, 43 (14.8%) had vitamin D insufficiency, and 13 (4.5%) had adequate levels of vitamin D. The demographic, anthropometric, and laboratory parameters of the 3 groups are summarized in Table II. Patients with vitamin D deficiency were significantly younger (p=0.01). The levels of anti-TPO, anti-TG and the number of patients positive for anti-TPO were significantly higher in the groups with vitamin D deficiency or insufficiency, compared to the group with sufficient vitamin D (p<0.001, p=0.026, p=0.006, respectively).

There were no significant differences between the 3 groups with respect to TSH, fT4, fT3 levels and the number of anti-TG positive patients (p>0.05).

Table II

Demographic, anthropometric, and laboratory parameters of subjects with vitamin D deficiency, insufficiency, and with sufficient vitamin D

Group with vitamin D deficiency (n=234)Group with vitamin D insufficiency (n=43)Group with sufficient vitamin D (n=13)p
Age, years 34±1037±1141±7 0.010
Sex, Female, n(%) 234 (100)43 (100)13 (100)-
BMI, kg/m2 26.17±6.2727.02±6.3426.31±4.630.709
Glucose, mg/dL 90.21±8.0091.79±8.4292.77±8.320.138
Urea, mg/dL 23.35±7.1021.60±4.9224.69±7.730.270
Creatinine, mg/dL 0.61±0.110.62±0.070.67±0.130.255
AST, U/L 17.88±5.8116.88±3.6717.92±4.250.543
ALT, U/L 15.91±10.5015.33±5.7014.62±4.170.877
fT4, ng/dL 1.08±0.141.07±0.181.05±0.160.652
fT3, ng/L 3.09±0.503.10±0.553.01±0.160.859
TSH, mlU/L 2.02±1.021.90±1.021.70±1.130.155
Anti TPO, IU/mL 251.89±442.37206.69±428.587.32±10.63 <0.001
Anti TG, IU/mL 39.00±136.8032.38±97.561.83±1.77 0.026
Patient prevalence
Anti TPO > 60 IU/mL91 (38.9)11 (25.6)0 (0.0) 0.006
Anti TG > 4.5 IU/mL64 (27.4)9 (20.9)1 (7.7)0.216

Abbreviations : BMI= Body mass index, AST= Aspartate aminotransferase; ALT= Alanine aminotransferase; fT4= free tetraiodotyronine; fT3= free triiodothyronine; TSH= thyroid stimulating hormone; Anti-TPO= thyroid peroxidase antibody; Anti-TG= thyroglobulin antibody; 25-OH D= 25-Hydroxy Vitamin D

The correlation analysis made to determine the association of vitamin D levels with thyroid autoantibodies and thyroid function tests showed a statistically significant negative correlation between vitamin D level and anti-TPO level(r=-0.133, p=0.023). However there was no significant relationship between vitamin D levels and TSH, fT4, fT3, and anti-TG levels (r=-0.093, p=0.113; r=-0.093, p=0.113; r=0.04, p=0.435 and r=-0.109, p=0.063, respectively) (Table III).

Table III

Correlation analysis between TSH, fT4, fT3, anti-TPO, anti-TG, and 25-OH D vitamin levels (Pearson Coefficient)

n=290TSHfT4fT3Anti-TPOAnti-TG25-OH D
TSH r 1.000-0.0710.0640.2960.169-0.093
p 0.2260.281 0.000 0.004 0.113
fT4 r 1.0000.079-0.017-0.0650.036
p 0.1800.7690.2700.546
fT3 r 1.0000.1180.0860.046
p 0.0440.1420.435
Anti-TPO r 1.0000.518-0.133
p 0.000 0.023
Anti-TG r 1.000-0.109
p 0.063

Abbreviations: TSH= thyroid stimulating hormone; fT4= free tetraiodothyronine; fT3= free triiodothyronine; Anti-TPO= thyroid peroxidase antibody; Anti-TG= thyroglobulin antibody; 25-OH D= 25-Hydroxy Vitamin D

The odds ratio was calculated for risk analysis when the cut-off value for vitamin D was taken as 20. In the presence of vitamin D deficiency there was a 3.107 fold increase in HT (%95 CI: 1.530 to 6.307, p= 0.001), and 2.604 fold increase in anti-TPO positivity (%95 CI: 1.280 to 5.291, p= 0.004).

Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results

Conclusion

In conclusion, this study showed a higher prevalence of vitamin D deficiency in HT patients compared to healthy controls, and also a higher prevalence of HT in patients with either deficiency or insufficiency of vitamin D compared to individuals with normal vitamin D levels. While a negative correlation was found between vitamin D and anti-TPO levels, there was no significant relationship between vitamin D and TSH, fT4, fT3, and anti-TG values. More comprehensive and prospective studies are needed to clarify the relationship between thyroid autoimmunity and vitamin D, and to determine the role of vitamin D supplementation in the prevention and alleviation of thyroid autoimmunity.

In the meantime, vitamin D screening should be carried out at the time of diagnosis or during follow up of patients diagnosed with HT, and replacement should be recommended if necessary.

Source: Conclusion
Authors’ abstract

Background

Vitamin D plays a role in numerous metabolic functions. In this study we aimed to assess vitamin D levels in Hashimoto's Thyroditis (HT) patients, and demonstrate the relationship between these levels and thyroid function tests or thyroid autoantibodies.

Methods

A retrospective analysis of 112 newly diagnosed euthyroid HT (EHT) patients and 178 healthy controls was carried out. 25-OH D level was classified as vitamin D deficiency, vitamin D insufficiency, and vitamin D sufficient.

Results

Mean age was 35.33±11.54 years in the patient group, and 35.84±10.9 in the control group (p=0.777). Compared with the healthy controls, patients in the EHT group had significantly lower vitamin D levels (p=0.007), and a significantly higher prevalence of vitamin D deficiency (p=0.001). While there was a negative correlation between vitamin D levels and anti-TPO values (r=-0.133, p=0.023), there was no significant relationship between vitamin D and TSH, fT4, fT3, and anti-TG values (p>0.05).

Conclusıons

This study showed that EHT patients had lower vitamin D levels compared to healthy controls, and there was a significant negative correlation between vitamin D levels and anti-TPO levels. Based on our study, patients diagnosed with HT should undergo vitamin D screening, and replacement if necessary.

Read the full paper

Introductıon

Hashimoto's thyroditis is a chronic autoimmune disease characterized by destruction of thyroid tissue, caused by lymphocytic infiltration. It has an annual incidence of 0.3-1.5 per 1000, and is the most common cause of hypothyroidism in areas of iodine sufficiency1,2. It is especially common in young and middle aged females, with a female to male ratio of 7/1 2. Although studies have stated that the disease is triggered by environmental factors in the presence of a genetic tendency, the etiology remains uncertain3.

The most commonly known risk factors include iodine excess, viral infections, chemicals, and drugs that stimulate antibody development such as amiodarone2. Recent studies focused on the efects of dietary factors, including deficiencies of vitamin D and selenium4. Because patients in early disease stages are generally euthyroid, they are asymptomatic and the diagnosis is made incidentally during routine screening. During the course, sublinical hypothyroidism, overt hypothroidism with or without goiter, or even thyroid cancer may develop sequentially5.

It is therefore important to detect and monitor the disease in the healthy population, and manage hypothyroidism.

Vitamin D is a secosteroid structured molecule produced in the skin. In addition to its fundamental role in bone mineralization and calcium metabolism, it also has important modulating effects on the immune system, exerted through the vitamin D receptor (VDR)6. Immunomodulator effects are exerted through VDR. Activation of VDR in immune cells leads to the transcription of gene products that trigger the antiproliferative and immune regulatory cascade6. Numerous studies have suggested that vitamin D deficiency is associated with autoimmune diseases, metabolic syndrome, chronic inflammatory disorders, cardiovascular diseases, and cancer7-10.

Despite numerous recent studies on the role of vitamin D in autoimmune thyroid diseases, the results are controversial11,12. There are also studies which suggest that vitamin D supplementation has a protective role in autoimmune thyroid diseases and thyroid cancers13.

The aim of this study is to analyze vitamin D levels in euthyroid Hashimoto's thyroiditis (EHT) patients and to demonstrate the relationship between vitamin D levels, thyroid function tests, and autoantibodies.

Methods

This study included 112 patients who presented to the internal medicine clinics of our hospital between 01.03.2023 and 01.06.2023, and who were diagnosed with HT by laboratory tests. The study also included 178 healthy controls who presented for a health screening during the same time period. All participants were females between ages 18-65 years. Patients who smoked or consumed alcohol, had comorbidities, a history of thyroidectomy or pregnancy, hormone replacement prior to presentation, use of anti thyroid or drugs that could affect thyroid function (e.g. amiodarone, lithium), and a history of vitamin D or calcium replacement during the previous 6 months were not included.

The study was carried out according to the declaration of Helsinki. All procedures in the study were approved by the Duzce University Ethical Board (Ethical board number: 2023/149). Informed consents were not taken because the study was retrospective.

Demographic and Laboratory Data

Subject data including age, sex, laboratory studies, and thyroid ultrasound results were retrieved from clinic files and retrospectively recorded on the hospital information system. Height and weight measurements on the hospital records were used to calculate the body mass index (BMI) (kg/m2). Blood samples were taken after minimum 8 hours of fasting. Fasting blood glucose (FBG), urea, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) were assessed with Beckman Coulter AU5800 device, free tetraiodothyronine (fT4), free triiodothyronine (fT3), thyroid stimulating hormone (TSH), thyroid peroxidase antibody (anti-TPO), thyroglobulin antibody (Anti-TG), and 25-Hydroxyvitamin D (25-OH D) were assessed with Siemens Advia Centaur XPT device.

Diagnostic Criteria

HT was diagnosed with a positive thyroid antibody test (anti-TPO>60 IU/mL and/or anti-TG>4.5 IU/mL) and presence of diffuse heterogeneity on ultrasound consistent with chronic thyroiditis. Euthyroidism was defined with TSH (0.35-5.5 mIU/L) and fT4 (0.83 to 1.43 ng/dL) levels within the normal reference range. Based on previous studies and guidelines, a 25-OH D level <20 µg/L was classified as vitamin D deficiency, 20-29.9 µg/L as vitamin D insufficiency, and ≥30 µg/L as sufficient vitamin D14,15.

Statistical Analysis

Descriptive analyses were carried out to provide comprehensive insights into the fundamental characteristics of the study cohort. Both visual representations, encompassing probability plots and histograms, along with rigorous analytical techniques such as the Kolmogorov-Smirnov and Shapiro-Wilk's tests, were employed to detect the normal distribution status of the data. Parametric assessments, especially the Independent Sample t-test, were applied to compare these parameters. The examination of categorical variables between the two distinct groups was made by the chi-square test. The categorical variables were shown in terms of frequency percentages.

For the investigation of data with parametric attributes involving multiple samples and repeated measures, a Repeated Measures Variance Analysis (ANOVA) was made. In this context, the Greenhouse-Geisser correction method was used. Given the normal distribution of both variables, the Pearson correlation coefficient in conjunction with its associated significance levels was calculated. The correlation analysis was also separately conducted for distinct work status categories. p<0.05 was set for statistical significance. All analytical procedures were executed utilizing the SPSS statistical software (IBM SPSS Statistics, Version 22.0.

Armonk, NY: IBM Corp.).

Results

A total of 290 women, including 112 (38.6%) EHT patients and 178 (61.4%) healthy controls, were included into the study. The demographic, anthropometric, and laboratory parameters of the EHT and healthy control groups are summarized in Table I. Mean age was 35.33±11.54 in the EHT group, and 35.84±10.95 in the healthy control group (p=0.777). Evaluation of the biochemical parameters showed that the EHT group had significantly higher levels of TSH, anti-TPO, and anti-TG levels (p<0.001), and lower fT4 and vitamin D levels compared to the healthy group (p<0.05).

Mean vitamin D level was 11.43±5.19 µg/L in the EHT group, and 14.53±8.25 µg/L in the healthy group. Classification of subjects in both groups with respect to vitamin D levels showed that the ratio of patients with vitamin D deficiency was significantly higher in the EHT than the healthy group (90.2% vs. 74.7%, respectively) (p=0.001). While there were 13 patients with normal vitamin D levels in the healthy group, there were no patients in the EHT group who had sufficient vitamin D levels.

Table I

Demographic, anthropometric, and laboratory parameters of EHT and healthy groups

Total (n=290)Healthy Group (n=178)EHT Group (n=112)p
Age, years 35.03±10.1735.84±10.9535.33±11.540.777
Sex, female, n(%) 290 (100)178 (100)112 (100)-
BMI, kg/m2 26.30±6.1825.65±5.2727.35±7.340.244
Glucose, mg/dL 90.56±8.0890.35±8.0590.89±8.160.945
Urea, mg/dL 23.15±6.8723.44±7.3622.69±6.010.572
Creatinine, mg/dL 0.61±0.100.62±0.100.60±0.110.159
AST, U/L 17.74±5.4917.83±5.1717.60±5.990.366
ALT, U/L 15.77±9.7215.43±8.3016.29±1.640.965
fT4, ng/dL 1.07±0.151.09±0.161.05±0.13 0.022
fT3, ng/L 3.09±0.153.07±0.523.13±0.490.387
TSH, mlU/L 1.99±1.021.78±0.882.33±1.14 <0.001
Anti TPO, IU/mL 234.23±432.6115.22±15.72582.30±536.38 <0.001
Anti TG, IU/mL 36.35±128.571.82±1.3493.23±195.16 <0.001
25-OH D, µg/L 13.33±7.3714.53±8.2511.43±5.19 0.007
Patient prevalence, n(%)
25-OH D<20 µg/L* 234 (80.7)133 (74.7)101 (90.2)
25-OH D:20-29.9 µg/L 43 (14.8)32 (18.0)11 (9.8) 0.001
25-OH D>30 µg/L* 13 (4.5)13 (7.3)0 (0.0)

*: There is a statistically significant difference between the groups. Abbreviations: EHT= Euthyroid Hashimoto's Thyroiditis, BMI= body mass index; AST= Aspartate aminotransferase; ALT= Alanine aminotransferase; fT4= free tetraiodothyronine; fT3= free triiodothyronine; TSH= thyroid stimulating hormone; Anti-TPO= thyroid peroxidase antibody; Anti-TG= thyroglobulin antibody; 25-OH D= 25-Hydroxy Vitamin D

The subjects were separated into 3 groups with respect to vitamin D levels: 234 (80.7%) had vitamin D deficiency, 43 (14.8%) had vitamin D insufficiency, and 13 (4.5%) had adequate levels of vitamin D. The demographic, anthropometric, and laboratory parameters of the 3 groups are summarized in Table II. Patients with vitamin D deficiency were significantly younger (p=0.01). The levels of anti-TPO, anti-TG and the number of patients positive for anti-TPO were significantly higher in the groups with vitamin D deficiency or insufficiency, compared to the group with sufficient vitamin D (p<0.001, p=0.026, p=0.006, respectively).

There were no significant differences between the 3 groups with respect to TSH, fT4, fT3 levels and the number of anti-TG positive patients (p>0.05).

Table II

Demographic, anthropometric, and laboratory parameters of subjects with vitamin D deficiency, insufficiency, and with sufficient vitamin D

Group with vitamin D deficiency (n=234)Group with vitamin D insufficiency (n=43)Group with sufficient vitamin D (n=13)p
Age, years 34±1037±1141±7 0.010
Sex, Female, n(%) 234 (100)43 (100)13 (100)-
BMI, kg/m2 26.17±6.2727.02±6.3426.31±4.630.709
Glucose, mg/dL 90.21±8.0091.79±8.4292.77±8.320.138
Urea, mg/dL 23.35±7.1021.60±4.9224.69±7.730.270
Creatinine, mg/dL 0.61±0.110.62±0.070.67±0.130.255
AST, U/L 17.88±5.8116.88±3.6717.92±4.250.543
ALT, U/L 15.91±10.5015.33±5.7014.62±4.170.877
fT4, ng/dL 1.08±0.141.07±0.181.05±0.160.652
fT3, ng/L 3.09±0.503.10±0.553.01±0.160.859
TSH, mlU/L 2.02±1.021.90±1.021.70±1.130.155
Anti TPO, IU/mL 251.89±442.37206.69±428.587.32±10.63 <0.001
Anti TG, IU/mL 39.00±136.8032.38±97.561.83±1.77 0.026
Patient prevalence
Anti TPO > 60 IU/mL91 (38.9)11 (25.6)0 (0.0) 0.006
Anti TG > 4.5 IU/mL64 (27.4)9 (20.9)1 (7.7)0.216

Abbreviations : BMI= Body mass index, AST= Aspartate aminotransferase; ALT= Alanine aminotransferase; fT4= free tetraiodotyronine; fT3= free triiodothyronine; TSH= thyroid stimulating hormone; Anti-TPO= thyroid peroxidase antibody; Anti-TG= thyroglobulin antibody; 25-OH D= 25-Hydroxy Vitamin D

The correlation analysis made to determine the association of vitamin D levels with thyroid autoantibodies and thyroid function tests showed a statistically significant negative correlation between vitamin D level and anti-TPO level(r=-0.133, p=0.023). However there was no significant relationship between vitamin D levels and TSH, fT4, fT3, and anti-TG levels (r=-0.093, p=0.113; r=-0.093, p=0.113; r=0.04, p=0.435 and r=-0.109, p=0.063, respectively) (Table III).

Table III

Correlation analysis between TSH, fT4, fT3, anti-TPO, anti-TG, and 25-OH D vitamin levels (Pearson Coefficient)

n=290TSHfT4fT3Anti-TPOAnti-TG25-OH D
TSH r 1.000-0.0710.0640.2960.169-0.093
p 0.2260.281 0.000 0.004 0.113
fT4 r 1.0000.079-0.017-0.0650.036
p 0.1800.7690.2700.546
fT3 r 1.0000.1180.0860.046
p 0.0440.1420.435
Anti-TPO r 1.0000.518-0.133
p 0.000 0.023
Anti-TG r 1.000-0.109
p 0.063

Abbreviations: TSH= thyroid stimulating hormone; fT4= free tetraiodothyronine; fT3= free triiodothyronine; Anti-TPO= thyroid peroxidase antibody; Anti-TG= thyroglobulin antibody; 25-OH D= 25-Hydroxy Vitamin D

The odds ratio was calculated for risk analysis when the cut-off value for vitamin D was taken as 20. In the presence of vitamin D deficiency there was a 3.107 fold increase in HT (%95 CI: 1.530 to 6.307, p= 0.001), and 2.604 fold increase in anti-TPO positivity (%95 CI: 1.280 to 5.291, p= 0.004).

Dıscussıon

Hashimoto's thyroiditis is the most common autoimmune thyroid disorder, and its incidence has shown an increase in recent years. During the course of the disease, patients may develop hypothyroidism, lymphoma possibly related to HT, and papillary thyroid cancer. An effective treatment that can prevent these has not been found 5. Based on the data acquired in the last 30 years, it is widely accepted that vitamin D plays a critical role in the modulation of the immune system. Although the pathogenesis of autoimmune thyroid diseases is not known completely, studies have shown a possible association between vitamin D deficiency and initiation or progression of the diseases16.

In our study we aimed to show the relationship between HT and vitamin D, and determine the correlation between thyroid function tests and autoantibodies with vitamin D levels.

The study included 290 women, 112 (38.6%) were EHT patients, and 178 (61.4%) were healthy controls. Mean age in the EHT group was 35±11 years, and was consistent with previous reports. Mean vitamin D level was 11.43±5.19 µg/L in the EHT group, and 14.53±8.25 in the healthy control group. Vitamin D level in the ETH group was significantly lower compared to the healthy control group (p<0.05). Also, when the subjects in both groups were classified according to vitamin D levels, the number of vitamin D deficient patients was significantly higher in the EHT group (90.2%) compared to the healthy group (74.7%) (p=0.001).

Similar to ours, previous studies found that HT patients had significantly lower levels of vitamin D and a higher prevalence of vitamin Deficiency compared to healthy controls17,18. Another study emphasized that there was a relationship between the severity of vitamin D and duration of HT, thyroid volume, and antibody levels. Also, vitamin D level had a potential role in the onset or progression of HT16. Contradictory to these data, a contemporary study published in 2021 and included 456 HT patients reported that there was no difference between HT patients and healthy controls with respect to vitamin D levels and prevalence of vitamin D deficiency4.

While the prevalence of vitamin D deficiency is investigated in HT patients, the prevalence of HT in patients with vitamin D deficiency was also studied. Studies showed that the incidence of HT is increased in patients with vitamin D deficiency, compared to those with normal vitamin D levels19,20. Prospective studies in which vitamin D replacement was given showed that anti-TPO and/or anti TG levels decreased significantly after vitamin D replacement. Ucan et al found that in EHT patients, vitamin D replacement led to a statistically significant decrease in antibody levels and thyroid volüme21.

In another study by Krysiak et al, the subjects received 2000 IU/day vitamin D replacement for 6 months22. At the end of this period serum vitamin D levels increased significantly, both anti-TPO and anti-TG levels decreased significantly with greater decreases in anti-TPO levels22. In our study, 80.7% of the patients had vitamin D deficiency and 14.8% had vitamin D insufficiency. Similar to previous tudies, comparison of the number of antibody positive patients and antibody titers between the groups showed that the anti-TPO and anti-TG levels and the number of anti-TPO positive patients were significantly higher in the groups with deficiency or insufficiency of vitamin D, compared to the group with sufficient vitamin D (p<0.001, p=0.026, p=0.006, respectively).

This showed us that there was a negative relationship between vitamin D levels and antibody levels.

Correlation analysis for determining the relationship between vitamin D and thyroid autoantibodies revealed statistically significant negative correlation between vitamin D levels and anti-TPO levels. (r=-0.133, p=0.023). Shin et al compared 111 antibody positive patients with 193 antibody negative patients, and found that levels of vitamin D were significantly lower in antibody positive patients23. In consistence with our study they also found a negative correlation between vitamin D and anti-TPO levels (r=-0.252; p<0.001)23. In some other important studies a negative correlation between vitamin D and anti-TG levels, however we did not find such a relationship20,24.

Studies evaluating the relationship between vitamin D and thyroid function tests showed that vitamin D level is associated with TSH, the higher the level of vitamin D the lower was the TSH level12,25. Chao et al found that with every 1ng/mL increase in vitamin D there was a 0.17 mIU/L decrease in TSH level, and they stated that vitamin D supplementation could play a role in preventing hypothyroidism15. However, this relationship was not confirmed by other studies.

A meta analysis that was published in 2021 and evaluated 6 clinical studies showed that vitamin D levels increased and anti-TPO titers decreased significantly with vitamin D replacement, however a relationship between vitamin D levels with thyroid function tests and anti-TG levels could not be found 26. Similarly, we did not find a significant correlation between vitamin D levels with either anti-TG levels or thyroid function tests. These findings show that anti-TPO is a better reflector of the effects of vitamin D on thyroid autoimmunity than the anti-TG.

The risk analysis in our study showed that in vitamin D deficiency, the presence of HT increased by 3.107 fold (OR: 3.107, %95 CI: 1.530-6.307, p= 0.001), and anti-TPO positivity increased by 2.604 fold (OR: 2.604, %95 CI: 1.280-5.291, p= 0.004). Mansournia et al showed that a 5 ng/ml increase in vitamin D level led to 19% decrease in odds of HT27.

Our study had some limitations. The retrospective and single center nature of the study, the relatively small number of EHT patients, and inclusion of only females were the major limitations. Although the lack of subclinical and overt hypothyroidism groups led to limitations in detecting the relationship between vitamin D and thyroid function tests, the inclusion of only newly diagnosed euthyroid patients rendered the patient group more specific. Another advantage of the study was its conduction in a single season to exclude seasonal factors.

Conclusion

In conclusion, this study showed a higher prevalence of vitamin D deficiency in HT patients compared to healthy controls, and also a higher prevalence of HT in patients with either deficiency or insufficiency of vitamin D compared to individuals with normal vitamin D levels. While a negative correlation was found between vitamin D and anti-TPO levels, there was no significant relationship between vitamin D and TSH, fT4, fT3, and anti-TG values. More comprehensive and prospective studies are needed to clarify the relationship between thyroid autoimmunity and vitamin D, and to determine the role of vitamin D supplementation in the prevention and alleviation of thyroid autoimmunity.

In the meantime, vitamin D screening should be carried out at the time of diagnosis or during follow up of patients diagnosed with HT, and replacement should be recommended if necessary.

Acknowledgments

We would like to thank the participants who agreed to participate in this study for their contribution to science.

Authors' Contributions

Study Design: Toçoğlu A, Genç AC, Asan FB, Önmez A

Data Collection: Toçoğlu A, Genç AC, Asan FB

Statistical Analysis: Genç AC, Asan FB

Data Interpretation: Toçoğlu A, Genç AC, Asan FB

Manuscript Preparation: Toçoğlu A, Genç AC, Önmez A

Literature Search: Toçoğlu AG, Önmez A

Funds Collection: Toçoğlu A, Asan FB, Önmez A

Conflict of Interest

The authors declare that they have no conflict of interest.

Availability of Data and Materials

The data and materials generated/analyzed in the present study are available from the corresponding author upon request.

Ethics Approval

All procedures in the study were approved by the Duzce University Ethical Board on 02.10.2023 (Ethical board number: 2023/149). This study was conducted in accordance with the Declaration of Helsinki.

Informed Consent

All participants signed the informed consent form before they were included in the study.

Funding

This research received no specific grant from any funding agency.

1 Ralli M Angeletti D Fiore M D'Aguanno V Lambiase A Artico M Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation Autoimmun Rev 2020 19 10 102649 32805423 10.1016/j.autrev.2020.102649
2 Turkish Endocrinology Society Thyroid Working GroupThyroid diseases diagnosis and treatment guide 2023 28 December 2023https://file.temd.org.tr/Uploads/publications/guides/documents/202305120904-2023tbl_kilavuz.pdf; 2023
3 Kust D Matesa N The impact of familial predisposition on the development of Hashimoto's thyroiditis Acta Clin Belg 2018 75 2 104 108 30570414 10.1080/17843286.2018.1555115
4 Cvek M Kaličanin D Barić A Vuletić M Gunjača I Torlak Lovrić V Vitamin D and Hashimoto's thyroiditis: Observations from CROHT biobank Nutrients 2021 13 8 2793 34444953 10.3390/nu13082793 PMC8401592
5 Moon S Chung HS Yu JM Yoo HJ Park JH Kim DS Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies Endocrinol Metab 2018 33 4 473 484 10.3803/EnM.2018.33.4.473 PMC6279904 30513562
6 Mele C Caputo M Bisceglia A Samà MT Zavattaro M Aimaretti G Immunomodulatory effects of vitamin D in thyroid diseases Nutrients 2020 12 5 1444 32429416 10.3390/nu12051444 PMC7284826
7 Plum LA DeLuca HF Vitamin D, disease and therapeutic opportunities Nat Rev Drug Discov 2010 9 12 941 955 21119732 10.1038/nrd3318
8 Sabbagh Z Markland J Vatanparast H Vitamin D status is associated with disease activity among rheumatology outpatients Nutrients 2013 5 7 2268 2275 23803739 10.3390/nu5072268 PMC3738972
9 Mahjoub SK SATTAR AHMAD MAA Kamel FO Alseini M Khan LM Preclinical study of vitamin D deficiency in the pathogenesis of metabolic syndrome in rats Eur Rev Med Pharmacol Sci 2022 26 23 9001 9014 36524519 10.26355/eurrev_202212_30575
10 Kose M Senkal N Tukek T Cebeci T Atalar SC Altinkaynak M Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis Eur Rev Med Pharmacol Sci 2022 26 19 7046 7052 36263552 10.26355/eurrev_202210_29888
11 Effraimidis G Badenhoop K Tijssen JG Wiersinga WM Vitamin D deficiency is not associated with early stages of thyroid autoimmunity Eur J Endocrinol 2012 167 1 43 48 22518050 10.1530/EJE-12-0048
12 Kim D Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis Hormones 2016 15 3 385 393 27394703 10.14310/horm.2002.1681
13 Roehlen N Doering C Hansmann ML Gruenwald F Vorlaender C Bechstein WO Vitamin D, FOXO3a, and Sirtuin1 in hashimoto's thyroiditis and differentiated thyroid cancer Front Endocrinol 2018 9 527 10.3389/fendo.2018.00527 PMC6142903 30271381
14 Holick MF Binkley NC Bischoff-Ferrari HA Gordon CM Hanley DA Heaney RP Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 2011 96 7 1911 1930 21646368 10.1210/jc.2011-0385
15 Chao G Zhu Y Fang L Correlation Between Hashimoto's Thyroiditis: Related Thyroid Hormone Levels and 25-Hydroxyvitamin D Fron Endocrinol 2020 11 4 10.3389/fendo.2020.00004 PMC7034299 32117049
16 Bozkurt NC Karbek B Ucan B Sahin M Cakal E Ozbek M The association between severity of vitamin D deficiency and Hashimoto's thyroiditis Endocr Pract 2013 19 3 479 484 23337162 10.4158/EP12376.OR
17 Štefanić M Tokić S Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto's thyroiditis: A systematic review, meta-analysis and meta-regression of observational studies Eur J Nutr 2020 59 3 859 872 31089869 10.1007/s00394-019-01991-w
18 Tamer G Arik S Tamer I Coksert D Relative vitamin D insufficiency in Hashimoto's thyroiditis Thyroid 2011 21 8 891 896 21751884 10.1089/thy.2009.0200
19 Nalbant A Gokosmanoglu F Cinemre H Varim C Kaya T Ergenc H The relation between serum vitamin D levels and Hashimoto thyroiditis in women Kuwait Med J 2017 49 3 223 226
20 Sulejmanovic M Begić A Mujaric-Bousbia F Salkic S Ramas A The relationship between thyroid antibodies and vitamin D level in primary hypothyroidism Med Arch 2020 74 5 359 33424090 10.5455/medarh.2020.74.359-362 PMC7780811
21 Ucan B Sahin M Sayki Arslan M Colak Bozkurt N Kizilgul M Güngünes A Vitamin D treatment in patients with Hashimoto's thyroiditis may decrease the development of hypothyroidism Int J Vitam Nutr Res 2016 86 1 9 17 28697689 10.1024/0300-9831/a000269
22 Krysiak R Szkróbka W Okopień B The effect of vitamin D on thyroid autoimmunity in levothyroxine-treated women with Hashimoto's thyroiditis and normal vitamin D status Exp Clin Endocrinol Diabetes 2017 125 4 229 233 28073128 10.1055/s-0042-123038
23 Shin DY Kim KJ Kim D Hwang S Lee EJ Low serum vitamin D is associated with anti-thyroid peroxidase antibody in autoimmune thyroiditis Yonsei Med J 2014 55 2 476 481 24532520 10.3349/ymj.2014.55.2.476 PMC3936621
24 Ahi S Dehdar MR Hatami N Vitamin D deficiency in non-autoimmune hypothyroidism: a case-control study BMC Endocr Disord 2020 20 1 1 6 32192469 10.1186/s12902-020-0522-9 PMC7082994
25 Gierach M Junik R The role of vitamin D in women with Hashimoto's thyroiditis Endokrynol Pol 2023 74 2 176 180 36916543 10.5603/EP.a2022.0095
26 Jiang H Chen X Qian X Shao S Effects of vitamin D treatment on thyroid function and autoimmunity markers in patients with Hashimoto's thyroiditis: A metaanalysis of randomized controlled trials J Clin Pharm Ther 2022 47 6 767 775 34981556 10.1111/jcpt.13605 PMC9302126
27 Mansournia N Mansournia MA Saeedi S Dehghan J The association between serum 25OHD levels and hypothyroid Hashimoto's thyroiditis J Endocrinol Invest 2014 37 5 473 476 24639121 10.1007/s40618-014-0064-y
Publication and source details

Original title: Correlation between Vitamin D levels and thyroid autoantibodies in newly diagnosed hashimoto's thyroiditis patients

Ahmed Cihad Genç; Aysel Toçoğlu; Fatma Betül Asan; Attila Önmez

African Health Sciences · 2025

Corresponding author: Ahmed Cihad, Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya, Turkey Phone: +902648884000, ORCİD ID: 0000-0002-7725-707X genccihad@gmail.com; acgenc@sakarya.edu.tr© 2025 Genç AC et al.2025https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:32:15.047741+00:00

DOI: 10.4314/ahs.v25i2.22 · PMC12361944